The headquarters of the U.S. Securities and Exchange Commission (SEC) are seen in Washington, July 6, 2009. REUTERS/Jim Bourg/File Photo Acquire Licensing RightsCompanies Nano-X Imaging Ltd FollowNEW YORK, Sept 29 (Reuters) - Nano-X Imaging (NNOX.O) and its founder Ran Poliakine agreed to pay nearly $1.1 million to settle U.S. Securities and Exchange Commission charges accusing the Israeli medical imaging company of negligently misleading investors about the cost to make its flagship product. The SEC said Nano-X also touted the misleadingly low estimate before and after its August 2020 initial public offering, which raised $165 million. Poliakine was Nano-X's chief executive at the time of the misleading statements, and is now non-executive chairman, the SEC said. Without admitting or denying wrongdoing, Nano-X and Poliakine agreed to pay respective civil fines of $650,000 and $150,000, and Poliakine will pay $267,000 in disgorgement plus interest.

---

Persons: Jim Bourg, Ran Poliakine, Poliakine, Jonathan Stempel, Chris Reese Organizations: U.S . Securities, Exchange Commission, SEC, REUTERS, X Imaging, U.S, Securities, Exchange, Thomson Locations: Washington, New York